Genmab — April 2019
-
He he
-
Enig Pensionist.
-
Infusionsstolene er jo kun et midlertidigt problem så kan ikke se det er noget at gå og ryste i bukserne over. Markedet burde allerede nu begynde at indregne den den subkutane version i deres dispositioner. Det er jo nok også derfor vi ser de store drenge igang med at samle billige Genmab aktier op og shorterne reducere.
-
Kapacitetsproblemerne har vel kun været adresseret i USA. Såvidt jeg ved har det ikke været beskrevet som et problem ROW.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind